Pharmaceutical Executive
June 01, 2013
Column
0
0
Despite their high status, management gurus aren't always on point when it comes to pharma, writes John Ansell.
June 01, 2013
From the Editor
0
0
Getting patients to take their medicine on spec and on time is the challenge that never goes away-it's the deadweight baggage accompanying every industry innovation since the arrival of aspirin a century ago.
June 01, 2013
Features
0
0
What is really driving decision making by the new Brazilian HTA agency? A look at appraisals issued in the first year.
June 01, 2013
Country Report
0
0
Ireland has been a pharma industry darling since the 1960s, when a then-newly established IDA targeted the sector as a strategic area for development. Today, the numbers are eyecatching. As reported by the IDA, nine out of the top 10 pharma companies in the world have substantial manufacturing operations in Ireland.
June 01, 2013
Column
0
0
Customer-focused supply-chain capabilities are becoming a more important part of a company's competitive advantage.
June 01, 2013
Column
0
0
Compounders are under increased scrutiny following last year's spinal meningitis outbreak.
June 01, 2013
Features
0
0
Led by two New Yorkers with a mindset that marries novel scientific insights to the processing power of novel technologies, Regeneron's success is a revolutionary challenge to the industry status quo.
June 01, 2013
Column
0
0
Project Data Sphere aims to liberate clinical trial data sets from industry and academic vaults, in an attempt to catalyze cancer research and discovery.